HPV Vaccine STudy
Participate in a vaccine program for persistent HPV type 16 or 18.
Human Papillomavirus (HPV) is the most common sexually transmitted infection (STI). Most people never have symptoms of HPV. However, the virus can still be spread without showing symptoms. A clinical research study is being conducted focusing on early disease interception of HPV.
Local doctors are looking for women 18-60 years old to participate in a clinical study for an investigational vaccine program which aims to generate a therapeutic vaccine for women with HPV types 16 or 18.
This study is open to women who:
Are between the ages of 18-60 years old
Have been diagnosed with persistent HPV types 16 or 18 for at least 12 months
Are willing and able to adhere to the prohibitions and restrictions specified to this study
Qualified participants may receive study-related care and vaccine at no cost. Compensation for time and travel may be available.
If you are interested in learning more about how to participate, fill out the form below.*
Please note that upon filling out and submitting the information below, you may be contacted by phone, and your information may be added into a database.